JPMorgan Chase & Co. Issues Pessimistic Forecast for Novavax (NASDAQ:NVAX) Stock Price
Novavax (NASDAQ:NVAX – Free Report) had its price objective reduced by JPMorgan Chase & Co. from $9.00 to $7.00 in a research report sent to investors on Friday,Benzinga reports. JPMorgan Chase & Co. currently has an underweight rating on the biopharmaceutical company’s stock. Other equities research analysts also recently issued reports about the stock. BTIG […]
Novavax (NASDAQ:NVAX – Free Report) had its price objective reduced by JPMorgan Chase & Co. from $9.00 to $7.00 in a research report sent to investors on Friday,Benzinga reports. JPMorgan Chase & Co. currently has an underweight rating on the biopharmaceutical company’s stock. Other equities research analysts also recently issued reports about the stock. BTIG […]
